Research graph
References from People with heart failure, sarcopenia and chagas disease: A systematic review and meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee
10.1016/j.cardfail.2019.03.007 · 2019 · External reference
Chagas Disease
10.7326/aitc202302210 · 2023 · External reference
SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023
2023 · External reference
Chagas Disease: Epidemiology and Barriers to Treatment
10.1016/j.amjmed.2020.05.022 · 2020 · External reference
Unresolved reference
External reference
Prevalence of clinical forms of Chagas disease: a systematic review and meta-analysis - data from the RAISE study
2024 · External reference
Current Approach to the Diagnosis of Sarcopenia in Heart Failure: A Narrative Review on the Role of Clinical and Imaging Assessments
10.1161/circheartfailure.121.009322 · 2022 · External reference
Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta-analysis and systematic review
10.1002/clc.23970 · 2023 · External reference
Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting
10.4330/wjc.v13.i1.1 · 2021 · External reference
Cachexia, muscle wasting, and frailty in cardiovascular disease
10.1002/ejhf.2011 · 2020 · External reference
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
10.7326/m14-2385 · 2015 · External reference
Sarcopenia: revised European consensus on definition and diagnosis
10.1093/ageing/afy169 · 2019 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
GRADE pearls and pitfalls-Part 1: Systematic reviews and meta-analyses
10.1111/aas.14386 · 2024 · External reference
Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022)
10.1007/s40520-022-02147-3 · 2022 · External reference
P4541Sarcopenia in non-cachectic males with heart failure
10.1093/eurheartj/ehz745.0932 · 2019 · External reference
Association of sarcopenia and oxygen uptake efficiency slope in male patients with heart failure: The skeletal muscle hypothesis in practice
10.1093/eurjpc/zwac056.011 · 2022 · External reference
Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies
10.1002/ehf2.12936 · 2020 · External reference
Discriminating sarcopenia in overweight/obese male patients with heart failure: the influence of body mass index
2020 · External reference
Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
10.1002/ejhf.1304 · 2018 · External reference
P4539Android to gynoid fat ratio and its association with functional capacity in male patients with heart failure
10.1093/eurheartj/ehz745.0930 · 2019 · External reference
Impact of Sarcopenia on the Prognosis in Heart Failure
10.1016/j.cardfail.2017.08.018 · 2017 · External reference
Sarcopenia in heart failure with reduced ejection fraction
2019 · External reference
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
10.1093/ageing/afq034 · 2010 · External reference
Epidemiology of sarcopenia among the elderly in New Mexico
10.1093/oxfordjournals.aje.a009520 · 1998 · External reference
Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia
10.1016/j.jamda.2013.11.025 · 2014 · External reference
Sarcopenia: alternative definitions and associations with lower extremity function
10.1046/j.1532-5415.2003.51534.x · 2003 · External reference
The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates
10.1093/gerona/glu010 · 2014 · External reference
Prevalence of Sarcopenia in Chronic Heart Failure and Modulating Role of Chronic Kidney Disease
10.1159/000536465 · 2024 · External reference
Relationship of Haptoglobin Phenotypes With Sarcopaenia in Patients With Congestive Heart Failure
10.1016/j.hlc.2022.01.003 · 2022 · External reference
Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis
10.1007/s12603-019-1267-x · 2020 · External reference
Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis
10.1002/jcsm.12783 · 2022 · External reference
Epidemiology of sarcopenia: Prevalence, risk factors, and consequences
10.1016/j.metabol.2023.155533 · 2023 · External reference
Screening, diagnosis and monitoring of sarcopenia: When to use which tool?
10.1016/j.clnesp.2022.01.027 · 2022 · External reference
Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis
10.1002/jcsm.13221 · 2023 · External reference
Sarcopenia in heart failure: a systematic review and meta-analysis
10.1002/ehf2.13255 · 2021 · External reference
Sarcopenia: imaging assessment and clinical application
10.1007/s00261-021-03294-3 · 2022 · External reference
Sarcopenia as a comorbidity of cardiovascular disease
10.1016/j.jjcc.2021.10.013 · 2022 · External reference
Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview
10.3389/fcvm.2021.743710 · 2021 · External reference
Pathogenesis of chronic Chagas heart disease
10.1161/circulationaha.106.624296 · 2007 · External reference
